| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO
1 company
Kakkis Emil D is a President &CEO at Ultragenyx Pharmaceutical Inc.. Recent SEC Form 4 filings include 3 buys and 16 sells.
Estimated insider holdings value: $19.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2021 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Sell | 30,000 | $141.80 | $4,254,000.00 | -1.3% | |
| Jan 4, 2021 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Sell | 30,000 | $136.90 | $4,107,000.00 | -1.3% | |
| Nov 2, 2020 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Sell | 30,000 | $96.82 | $2,904,600.00 | -1.3% | |
| Sep 1, 2020 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Sell | 30,000 | $82.63 | $2,478,900.00 | -1.2% | |
| Jul 13, 2020 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Sell | 40,000 | $85.35 | $3,414,000.00 | -1.6% | |
| Sep 11, 2019 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Buy | 5,000 | $43.63 | $218,150.00 | +1.1% | |
| Aug 28, 2017 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Buy | 7,500 | $52.52 | $393,922.32 | +0.1% | |
| Nov 15, 2016 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Sell | 20,000 | $81.29 | $1,625,753.15 | -0.9% | |
| Oct 14, 2016 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Sell | 20,000 | $63.02 | $1,260,360.40 | -1.0% | |
| Aug 15, 2016 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Sell | 20,000 | $67.61 | $1,352,250.81 | -2.0% |